Great Lakes Advisors LLC Cuts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Great Lakes Advisors LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 39.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,353 shares of the medical equipment provider’s stock after selling 5,348 shares during the quarter. Great Lakes Advisors LLC’s holdings in Intuitive Surgical were worth $3,736,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Rossmore Private Capital lifted its position in shares of Intuitive Surgical by 2.0% during the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after purchasing an additional 20 shares in the last quarter. Vertex Planning Partners LLC grew its position in Intuitive Surgical by 2.3% in the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after purchasing an additional 21 shares in the last quarter. Accredited Investors Inc. increased its stake in Intuitive Surgical by 2.0% in the 3rd quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock valued at $474,000 after buying an additional 21 shares during the last quarter. True Vision MN LLC lifted its position in shares of Intuitive Surgical by 3.0% during the 2nd quarter. True Vision MN LLC now owns 766 shares of the medical equipment provider’s stock worth $416,000 after buying an additional 22 shares in the last quarter. Finally, Evermay Wealth Management LLC lifted its position in shares of Intuitive Surgical by 3.1% during the 2nd quarter. Evermay Wealth Management LLC now owns 731 shares of the medical equipment provider’s stock worth $397,000 after buying an additional 22 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on ISRG shares. BTIG Research reaffirmed a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research report on Friday, January 23rd. Piper Sandler reaffirmed an “overweight” rating and set a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Raymond James Financial boosted their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Daiwa Capital Markets increased their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Finally, Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday. Two research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $620.41.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 464 shares of the company’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36. Following the sale, the senior vice president directly owned 131 shares in the company, valued at $71,852.19. This represents a 77.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares of the company’s stock, valued at $1,772,480. This trade represents a 81.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 75,683 shares of company stock worth $42,066,425 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 0.7%

Shares of ISRG stock opened at $504.22 on Friday. The firm’s 50 day moving average is $558.64 and its 200 day moving average is $511.63. The stock has a market capitalization of $180.75 billion, a P/E ratio of 63.91, a PEG ratio of 3.92 and a beta of 1.67. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.21 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.